Skip to main content
. 2020 Feb 7;12(4):325–337. doi: 10.4155/fmc-2019-0266

Figure 5. . Annexin V-FITC/propodium iodide staining and cell viability by trypan blue exclusion, demonstrating cotreatment with exogenous carbon monoxide sensitizes human breast cancer cell line MCF-7 to conventional chemotherapeutics, doxorubicin and paclitaxel.

Figure 5. 

Data representative of at least n = 3 individual experiments.

*p< 0.05.

CO: Carbon monoxide.